Bessemer Group’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22K | Buy |
174
+14
| +9% | +$1.77K | ﹤0.01% | 1543 |
|
|
2025
Q1 | $14K | Sell |
160
-77
| -32% | -$6.74K | ﹤0.01% | 1637 |
|
|
2024
Q4 | $21K | Sell |
237
-765
| -76% | -$67.8K | ﹤0.01% | 1500 |
|
|
2024
Q3 | $92K | Buy |
1,002
+157
| +19% | +$14.4K | ﹤0.01% | 1296 |
|
|
2024
Q2 | $91K | Hold |
845
| – | – | ﹤0.01% | 1191 |
|
|
2024
Q1 | $80K | Hold |
845
| – | – | ﹤0.01% | 1213 |
|
|
2023
Q4 | $78K | Buy |
845
+51
| +6% | +$4.71K | ﹤0.01% | 1262 |
|
|
2023
Q3 | $40K | Hold |
794
| – | – | ﹤0.01% | 1372 |
|
|
2023
Q2 | $50K | Hold |
794
| – | – | ﹤0.01% | 1376 |
|
|
2023
Q1 | $36K | Buy |
+794
| New | +$36K | ﹤0.01% | 1279 |
|
|
2020
Q3 | – | Sell |
-5,100
| Closed | -$398K | – | 1374 |
|
|
2020
Q2 | $398K | Buy |
+5,100
| New | +$398K | ﹤0.01% | 1021 |
|